Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;102(3):326-38.
doi: 10.1016/j.ymgme.2010.11.164. Epub 2010 Dec 2.

Research challenges in central nervous system manifestations of inborn errors of metabolism

P I Dickson  1 , A R Pariser, S C Groft, R W Ishihara, D E McNeil, D Tagle, D J Griebel, S G Kaler, J W Mink, E G Shapiro, K J Bjoraker, L Krivitzky, J M Provenzale, A Gropman, P Orchard, G Raymond, B H Cohen, R D Steiner, S F Goldkind, R M Nelson, E Kakkis, M C Patterson
Affiliations
Review

Research challenges in central nervous system manifestations of inborn errors of metabolism

P I Dickson et al. Mol Genet Metab. 2011 Mar.

Abstract

The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups.

PubMed Disclaimer

References

    1. Orphan Drug Act, Pub. L.97–414. 96 Stat. 2049 (1984 as amended).

    1. Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA for the rare diseases clinical research network. Clinical research for rare disease: Opportunities, challenges, and solutions. Mol Genet Metab. 2009;96:20–26. - PMC - PubMed
    1. Kaler SG. ATP7A-relatedcopper transport diseases-emerging concepts and future trends. Nat Rev Neurol. in press. - PMC - PubMed
    1. Kaler SG, Holmes CS, Goldstein DS, Tang JR, Godwin SC, Donsante A, Liew CJ, Sato S, Patronas N. Neonatal diagnosis and treatment of Menkes disease. N Engl J Med. 2008;358:605–614. - PMC - PubMed
    1. Kaler SG, Donsante A, Tang JR, Goldstein DS, Holmes CS, Sullivan P, Centeno JA. Brain-directed AAV5 gene therapy, in combination with copper, rescues a murine model of severe Menkes disease. Presented at the 59th Annual Meeting of The American Society of Human Genetics; October 24, 2009; Honolulu, Hawaii. Available at http://www.ashg.org/2009meeting/abstracts/fulltext/

Publication types

MeSH terms

LinkOut - more resources